ciprofloxacin has been researched along with Tachycardia, Ventricular in 3 studies
Ciprofloxacin: A broad-spectrum antimicrobial carboxyfluoroquinoline.
ciprofloxacin : A quinolone that is quinolin-4(1H)-one bearing cyclopropyl, carboxylic acid, fluoro and piperazin-1-yl substituents at positions 1, 3, 6 and 7, respectively.
Tachycardia, Ventricular: An abnormally rapid ventricular rhythm usually in excess of 150 beats per minute. It is generated within the ventricle below the BUNDLE OF HIS, either as autonomic impulse formation or reentrant impulse conduction. Depending on the etiology, onset of ventricular tachycardia can be paroxysmal (sudden) or nonparoxysmal, its wide QRS complexes can be uniform or polymorphic, and the ventricular beating may be independent of the atrial beating (AV dissociation).
| Excerpt | Relevance | Reference |
|---|---|---|
| "Each patient group that was prescribed ciprofloxacin, levofloxacin, ofloxacin or moxifloxacin was compared with the group that was prescribed cefixime to assess the risk of serious ventricular arrhythmia (ventricular tachycardia, fibrillation, flutter and cardiac arrest)." | 7.88 | Association of oral ciprofloxacin, levofloxacin, ofloxacin and moxifloxacin with the risk of serious ventricular arrhythmia: a nationwide cohort study in Korea. ( Cho, Y; Park, HS, 2018) |
| "Each patient group that was prescribed ciprofloxacin, levofloxacin, ofloxacin or moxifloxacin was compared with the group that was prescribed cefixime to assess the risk of serious ventricular arrhythmia (ventricular tachycardia, fibrillation, flutter and cardiac arrest)." | 3.88 | Association of oral ciprofloxacin, levofloxacin, ofloxacin and moxifloxacin with the risk of serious ventricular arrhythmia: a nationwide cohort study in Korea. ( Cho, Y; Park, HS, 2018) |
| "Ciprofloxacin has been widely used for treating infections and has been found to have very low cardiovascular side effects." | 1.31 | Ciprofloxacin-induced QTc prolongation. ( Gupta, MS; Jain, S; Khetarpal, S; Kishore, K; Mangla, M; Singh, H, 2002) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cho, Y | 1 |
| Park, HS | 1 |
| Kaźmierczak, J | 1 |
| Peregud-Pogorzelska, M | 1 |
| Rzeuski, R | 1 |
| Singh, H | 1 |
| Kishore, K | 1 |
| Gupta, MS | 1 |
| Khetarpal, S | 1 |
| Jain, S | 1 |
| Mangla, M | 1 |
3 other studies available for ciprofloxacin and Tachycardia, Ventricular
| Article | Year |
|---|---|
Association of oral ciprofloxacin, levofloxacin, ofloxacin and moxifloxacin with the risk of serious ventricular arrhythmia: a nationwide cohort study in Korea.
Topics: Administration, Oral; Aged; Anti-Bacterial Agents; Arrhythmias, Cardiac; Cefixime; Ciprofloxacin; Co | 2018 |
QT Interval prolongation and torsades de pointes due to a coadministration of ciprofloxacin and azimilide in a patient with implantable cardioverter-defibrillator.
Topics: Aged; Anti-Arrhythmia Agents; Anti-Infective Agents; Ciprofloxacin; Defibrillators, Implantable; Dru | 2007 |
Ciprofloxacin-induced QTc prolongation.
Topics: Adult; Anti-Infective Agents; Ciprofloxacin; Electric Countershock; Electrocardiography; Female; Hum | 2002 |